Comments

Purple Biotech

PPBTNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.398000
0.023.94%
Last update: 9:17 AM
15 minutes delayed
Purple Biotech (PPBT) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$8.00
Consensus Price Target1
$10.00

want to know what
the Bulls & Bears Say?

Purple Biotech (NASDAQ:PPBT) Stock, Analyst Ratings, Price Targets, Forecasts

Purple Biotech Ltd has a consensus price target of $10 based on the ratings of 4 analysts. The high is $11 issued by Chardan Capital on March 7, 2024. The low is $8 issued by JonesTrading on July 21, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 11, 2024, May 21, 2024, and April 26, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 2545.50% upside for Purple Biotech Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Feb
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Chardan Capital
JonesTrading
Chardan Capital

1calculated from analyst ratings

Analyst Ratings for Purple Biotech

Buy NowGet Alert
07/11/2024Buy Now2545.5%HC Wainwright & Co.
Emily Bodnar
$10 → $10ReiteratesBuy → BuyGet Alert
05/21/2024Buy Now2545.5%HC Wainwright & Co.
Emily Bodnar
 → $10ReiteratesBuy → BuyGet Alert
04/26/2024Buy Now2545.5%HC Wainwright & Co.
Emily Bodnar
 → $10ReiteratesBuy → BuyGet Alert
03/07/2024Buy Now2810.05%Chardan Capital
Daniil Gataulin
$11 → $11MaintainsBuyGet Alert
03/05/2024Buy Now2545.5%HC Wainwright & Co.
Emily Bodnar
 → $10ReiteratesBuy → BuyGet Alert
02/27/2024Buy Now2545.5%HC Wainwright & Co.
Emily Bodnar
 → $10ReiteratesBuy → BuyGet Alert
11/21/2023Buy Now2545.5%HC Wainwright & Co.
Emily Bodnar
$9 → $10MaintainsBuyGet Alert
08/31/2023Buy Now2280.95%HC Wainwright & Co.
Emily Bodnar
$7 → $9MaintainsBuyGet Alert
08/30/2023Buy Now2280.95%HC Wainwright & Co.
Emily Bodnar
$7 → $9MaintainsBuyGet Alert
07/21/2023Buy Now2016.4%JonesTrading
Catherine Novack
 → $8Initiates → BuyGet Alert
05/17/2023Buy Now1751.85%HC Wainwright & Co.
Emily Bodnar
 → $7ReiteratesBuy → BuyGet Alert
05/17/2023Buy Now2810.05%Chardan Capital
Matthew Barcus
 → $11ReiteratesBuy → BuyGet Alert
02/09/2023Buy Now1751.85%HC Wainwright & Co.
Emily Bodnar
 → $7Reiterates → BuyGet Alert
02/09/2023Buy Now2810.05%Chardan Capital
Matthew Barcus
 → $11Reiterates → BuyGet Alert
10/17/2022Buy Now1751.85%HC Wainwright & Co.
Emily Bodnar
 → $7Initiates → BuyGet Alert
09/08/2022Buy Now2810.05%Chardan Capital
Matthew Barcus
 → $11Initiates → BuyGet Alert

FAQ

Q

What is the target price for Purple Biotech (PPBT) stock?

A

The latest price target for Purple Biotech (NASDAQ:PPBT) was reported by HC Wainwright & Co. on July 11, 2024. The analyst firm set a price target for $10.00 expecting PPBT to rise to within 12 months (a possible 2412.56% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Purple Biotech (PPBT)?

A

The latest analyst rating for Purple Biotech (NASDAQ:PPBT) was provided by HC Wainwright & Co., and Purple Biotech reiterated their buy rating.

Q

When was the last upgrade for Purple Biotech (PPBT)?

A

There is no last upgrade for Purple Biotech

Q

When was the last downgrade for Purple Biotech (PPBT)?

A

There is no last downgrade for Purple Biotech.

Q

When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.

Q

Is the Analyst Rating Purple Biotech (PPBT) correct?

A

While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a reiterated with a price target of $10.00 to $10.00. The current price Purple Biotech (PPBT) is trading at is $0.40, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch